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ABSTRACT
Purpose: Interleukin (IL)-17 variants and perturbations in the gut microbiota may influence 
the development of atopic dermatitis (AD). However, unifying principles for variants of host 
and microbe interaction remains unclear. We sought to investigate whether IL-17 variants and 
gut microbiota affect the development of AD in infancy.
Methods: Composition of the gut microbiota was analyzed in fecal samples from 99 
normal healthy and 61 AD infants at 6 months of age. The associations between total 
immunoglobulin E (IgE), the scoring atopic dermatitis (SCORAD), short-chain fatty acids, 
transcriptome and functional profile of the gut measured in these subjects and Streptococcus 
were analyzed. IL-6 and IL-8 in the human intestinal epithelial cell line (HIEC-6) were 
measured after stimulation of IL-17 and Streptococcus mitis.
Results: In this study, Streptococcus was enriched in infants with AD and was higher in those 
with the GA + AA of IL-17 (rs2275913) variant. Streptococcus was positively correlated with IgE 
and SCORAD in infants with AD and GA + AA of IL-17. Butyrate and valerate were negatively 
correlated with Streptococcus and were decreased in infants with AD and GA + AA. Bacterial 
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genes for oxidative phosphorylation induced by reduced colonization of Clostridium were 
decreased compared with normal and GG. In transcriptome analysis, lactate dehydrogenase 
A-like 6B was higher in infants with AD compared with healthy infants. IL-6 and IL-8 were 
increased in IL-17 and/or S. mitis-stimulated HIEC-6 cells.
Conclusions: These findings suggest that increased Streptococcus and A allele of IL-17 (rs2275913) 
may contribute to the pathogenesis of AD via modulation of the immune system in infancy.
Keywords: Atopic dermatitis; gastrointestinal microbiome; Streptococcus; IL-17
INTRODUCTION
Atopic dermatitis (AD) is one of the most common inflammatory diseases in children. 
Several studies have shown that the prevalence of AD has increased significantly over the 
last 3 decades, particularly in developed countries.1 Although reasons for this increase are 
not fully understood, the etiology of AD is believed to be multifactorial with an interaction 
between genetics, immune, and environmental factors, such as birth mode, use of 
antibiotics, intake of westernized food, and low helminth burden, which is in line with 
the ‘hygiene hypothesis.’2,3 These environmental factors contribute to an alteration in the 
composition of the gut microbiota and a subsequent change in the immune system.4,5 Many 
recent studies have indicated that the gut microbiota is involved in the pathogenesis of 
allergic diseases, including AD, in infants.6-8 These data imply that the gut microbiota play a 
critical role in the development of AD.
Host genetic variants can affect the variation of the gut microbiota between individuals. 
For example, the gut microbiota of monozygotic twins has a significantly higher degree 
of similarity than that of dizygotic twins.9,10 In addition, Bacteroides fragilis delivers 
immunomodulatory molecules to immune cells through the outer membrane vesicles 
(OMVs). Immune cells from human subjects with a major risk variant in ATG16L1 
inflammatory bowel disease (IBD)-associated genes are defective in regulatory T cells 
responses to OMVs.11 Taken together, these studies indicate that host genetics influences the 
composition of the human gut microbiota and can do so in ways that impact on host disease 
development. However, no studies have investigated the interaction between the host genetic 
variants and the gut microbiota of individuals in relation to AD.
Th17 cells define a subset of T-helper cells that mainly produce interleukin (IL)-17A, IL-17F, 
and IL-22, which play a critical role in inflammation.12 In gut mucosal immunity, IL-17-
expressing cells were increased in the gut lamina propria of patients with Crohn's disease13 
and the expression of IL-17 was increased in the mucosa and serum of subjects with IBD.14 
In addition, several bacteria are involved in the differentiation of Th17 cells in the lamina 
propria of mice15,16 and IL-17 is associated with the colonization of Streptococcus pyogenes in 
the human genital tract, but not in the gut.17 From a genetic perspective, A allele of IL-17 
variant (rs2275913) in the promoter affects the expression of IL-1718 and is associated with the 
development and severity of AD.19,20 These previous studies demonstrate that the IL-17 variant 
(rs2275913) and gut microbiota are likely to affect the development of AD, either individually 
or in combination. However, this process remains unclear in patients with AD. To address 
this, the current study sought to investigate whether the gut microbiota is controlled by 
the IL-17 variant rs2275913 and whether an interaction between the 2 factors affects the 
development of AD in infants.
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MATERIALS AND METHODS
Subjects
Patients were enrolled from the Cohort for Childhood Origin of Asthma and Allergic Diseases 
birth cohort and the Asthma and Allergy Clinic of the Asan Medical Center of South Korea. 
Infants who received antibiotics prior to fecal collection were excluded. AD was diagnosed 
at 6 and 12 months of age by a pediatric allergist and total serum immunoglobulin E (IgE) 
levels were measured using the UniCAP fluoroenzyme immunoassay (Pharmacia Diagnostics, 
Uppsala, Sweden) at 12 months of age. The scoring atopic dermatitis (SCORAD) index21 
was assessed by a pediatric allergist at 6 and 12 months of age. This study was approved 
by the Institutional Review Boards (IRBs) of the Asan Medical Center (IRB No. 2008-0616 
and 2015-1031), Samsung Medical Center (IRB No. 2009-02-021), Severance Hospital (IRB 
No. 4-2008-0588), the CHA Medical Center (IRB No. 2010-010), and the Seoul National 
University Hospital (IRB No. H-1401-086-550). Written, informed consent was obtained from 
the parents of each infant.
Fecal sample collection, 16S ribosomal RNA (rRNA) gene pyrosequencing, 
and MiSeq sequencing
Fecal samples were collected from infants at 6 months of age and were immediately frozen 
at −80°C before being processed for DNA extraction. Briefly, DNA was extracted using the 
Power Microbiome RNA/DNA Isolation kit (Mo Bio/Qiagen, Carlsbad, CA, USA) according 
to the manufacturer's instructions. For pyrosequencing (106 infants) and MiSeq sequencing 
(54 infants), the extracted DNA was amplified using barcoded primers targeting the V1-V3 
region of the 16S rRNA gene. The details are described in a previous study.6,22 To resolve the 
difference between 2 sequencing methods, commonly detected bacteria were included in the 
microbiome analysis.
Genotyping of the IL-17 (rs2275913) variant
Genomic DNA was isolated from cord blood using the Gentra Puregene® Blood kit (Qiagen, 
Germantown, MD, USA). The IL-17 variant (rs2275913) was genotyped using a TaqMan 
assay (Applied Biosystems, Foster City, CA, USA) in accordance with the manufacturer's 
instructions. The assay ID number for the SNP was C_15879983_10. The final volume from 
polymerase chain reaction (PCR) was 5 µL, containing 10 ng genomic DNA, 2.5 µL TaqMan 
Universal PCR Master Mix, and 0.13 µL of 40 × assay mix. All PCRs were performed in 
384 well plates using a 384 Well Veriti thermal cycler (Applied Biosystems). The endpoint 
fluorescent readings were performed on an ABI PRISM 7900 HT Sequence Detection System 
(Applied Biosystems). Duplicate samples and negative controls were included to ensure 
genotyping accuracy.
Measurement of short-chain fatty acids (SCFAs)
The levels of SCFAs (acetate, propionate, butyrate, and valerate) were measured from fecal 
samples of infants at 6 months of age. Briefly, 100 mg fecal samples were diluted at a ratio 
of 1:4 (w/v) in deionized water. The samples were then vigorously vortexed and supernatants 
were collected after centrifugation. Supernatants were extracted by shaking with internal 
standard solution, 20 μL 0.6 N HCl, and 2 mL diethyl ether. After centrifugation, the upper 
layer was collected and was completely dried under vacuum. The samples were reconstituted 
with 100 μL acetonitrile. SCFAs were analyzed by gas chromatography-mass spectrometry 
(7890A/5975A; Agilent, Waldbronn, Germany) and a HP-5MS 30 m × 250 μm × 0.25-μm 
column (Agilent 19091S-433). The details are described in a previous publication.23
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Whole-metagenome sequencing and analysis
A total of 88 samples with a sufficient amount of feces were selected from each group (19 
normal with GG genotype, 34 normal with GA + AA genotypes, 11 AD with GG genotype, and 
24 AD with GA + AA genotypes) and used for whole-metagenome sequencing. The details are 
described in a previous publication.6
Colonocyte isolation from fecal samples and transcriptome
Transcriptome data were generated for 20 subjects (10 normal and 10 AD). For the isolation 
of exfoliated colonocytes, 0.5 g of the fecal samples were thawed, vortexed with 10 mL 
phosphate-buffered saline (PBS), and filtered through a 40-μm cell strainer (SPL, Seoul, 
Korea). The resulting filtrate was gently overlaid on Histopaque-1077 (Sigma Aldrich, St. 
Louis, MO, USA) and centrifuged at 400 × g for 30 minutes at room temperature. After 
centrifugation, the layer containing cells was washed twice with 10 mL PBS. Total RNA was 
extracted using the RNeasy Mini kit according to the manufacturer's instructions (Qiagen, 
Hilden, Germany). Gene expression analysis was performed using Affymetrix GeneChip 
Human Gene 2.0 ST Arrays (Thermo Fisher Scientific, Inc., Waltham, MA, USA). All of the 
procedures, including array hybridization and scanning, were performed independently 
according to the standard protocol.
Human intestinal epithelial cell-6 (HIEC-6) cell stimulation by IL-17 and 
Streptococcus mitis
The HIEC-6 cell line (CRL3266) was purchased from the American Type Culture Collection 
(ATCC, Manassas, VA, USA) and was maintained at 37°C in a humidified incubator at 5% 
CO2 in opti-MEM (Gibco, Grand Island, NY, USA) culture medium supplemented with 20 
mM HEPES buffer, 10 mM GlutaMAX, 10 ng/mL epidermal growth factor, 4% fetal bovine 
serum, and 1% penicillin-streptomycin. S. mitis strain (ATCC® 49456™) was obtained from 
the ATCC and grown overnight in brain heart infusion broth supplemented with 0.4% yeast 
extract and 1% b-cyclodextrin at 37°C in a humidified bacterial incubator at 10% CO2. The 
S. mitis was pelleted, washed in sterile PBS, and resuspended in sterile opti-MEM media 
without antibiotics at a concentration of 5 × 107 bacteria/mL. Recombinant human IL-17 (R&D 
Systems, Lille, France) was resuspended in sterile PBS. HIEC-6 cells (5 × 105) were seeded 
in a 60 mm cell culture dish. The next day, the cells were washed with PBS and cultured in 
media without antibiotics. HIECs were cultured in opti-MEM (Gibco) culture medium either 
alone or in the presence of IL-17 only for 24 hours, S. mitis (multiplicity of infection 1:100) 
only for 6 hours, or a combination of both. In the case of the combination, after 18 hours of 
IL-17 stimulation, S. mitis was added and incubated for 6 hours; the cells were harvested at the 
same time.
Measurement of IL-6 and IL-8
The amount of the pro-inflammatory cytokines IL-6 and IL-8 produced by HIEC-6 in 
response to IL-17 alone, S. mitis alone or a combination of both was measured using real-
time PCR. Total RNA was extracted using the RNeasy Mini kit (Qiagen) and complementary 
DNA was synthesized using the WizScript™ cDNA Synthesis Kit (Wizbio, Seongnam, 
Korea) according to the manufacturer's instructions. Real-time PCR was carried out using 
predesigned TaqMan primers and probes for IL-6 (assay No, Hs00174131_m1), IL-8 (assay No, 
Hs00174103_m1), and glyceraldehyde 3-phosphate dehydrogenase (assay No, Hs02786624_
g1) as an endogenous control. Analysis was carried out using the ABI PRISM 7900 Sequence 
Detection System (Applied Biosystems) in accordance with the manufacturer's instructions.
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Statistical analysis
Continuous variables were compared among the groups by the Kruskal-Wallis test, and 
categorical variables were compared using Fisher's exact test. Continuous variables after 
adjustment for diagnosis of AD, delivery mode, and feeding type were compared using the 
general linear model. Linear discriminant analysis effect size (LEfSe) was used to elucidate 
differences in bacterial taxa among the groups. The difference of Streptococcus according to 
IL-17 variant and AD was compared by analysis of variance (ANOVA), followed by Tukey's 
test. Correlations between 2 continuous variables were analyzed by Spearman correlation 
coefficient. In whole-metagenome sequencing analysis, the number of bacteria contributing 
to the metabolic pathway used genus instead of species. Differentially expressed genes (DEGs) 
were filtered through statistical estimation of fold change (FC) ≥ 1.5 and P < 0.05 based 
on Student's t-test. Functional enrichment analysis was performed to identify significant 
biological pathways, including gene ontology terms. Results of real-time PCR are reported as 
the mean ± standard error of triplicate samples. ANOVA followed by Tukey's test was applied 
to in vitro studies. A P value < 0.05 was considered to indicate a significant difference.
RESULTS
Characteristics of the study subjects
A total of 160 infants (99 normal healthy controls, 61 patients with AD) were included. 
There were no significant differences in sex, gestational age, birth weight, delivery mode, or 
feeding type between healthy infants and infants with AD (Table 1). The total IgE levels were 
higher in the AD group compared with the normal healthy group (P = 0.030, Table 1).
Gut microbiota composition
The gut microbiota were first analyzed in the normal healthy and AD groups. Diversity indices 
(observed OTUs, Chao1, and Shannon diversity index) showed no significant differences 
between the 2 groups (Supplementary Fig. S1). However, a difference was seen between 
the groups in gut microbial taxa using LEfSe. Excluding low abundance (<1% mean relative 
abundance in each group and distributed to <30% of the subjects), the results indicated 
that Streptococcus and Lactobacillus were markedly increased in the AD group, while Clostridium, 
Clostridium g4 and Clostridium g6 were enriched in the normal healthy group (Fig. 1A). The 
relationship between the IL-17 variant (rs2275913) and development of AD at 6 months of age 
was analyzed by a dominant model. The IL-17 variant (rs2275913) was not associated with a 
significant change in the development of AD, SCORAD score at 6 month of age or total IgE 
levels at 12 months of age (Supplementary Fig. S2). The association between the IL-17 variant 
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Table 1. Demographic characteristics of the study subjects
Characteristics Normal healthy AD P value
No. 99 61
Male/female 53/46 40/21 0.142*
Gestational age (wk) 39.40 ± 0.11 39.15 ± 0.20 0.723†
Birth weight (g) 3,265.92 ± 43.52 3,159.38 ± 60.51 0.295†
Delivery mode (% cesarean) 30.30 24.59 0.471*
Feeding type (% breast milk) 32.32 37.70 0.608*
Log IgE (IU/mL) 1.22 ± 0.06 1.51 ± 0.10 0.030†
Log SCORAD ND 22.90 ± 2.26 NA
SCFAs (measurement %) 54.55 26.23 0.001*
Data are shown as the mean ± standard error.
AD, atopic dermatitis; IgE, immunoglobulin E; ND, not done; NA, not available; SCORAD, scoring atopic dermatitis; SCFA, short chain fatty acids.
*Fisher's exact test; †Mann-Whitney test.
(rs2275913) and AD-related gut microbial taxa (Streptococcus, Lactobacillus, Clostridium, Clostridium 
g4, and Clostridium g6) was then determined. Streptococcus was significantly increased in the 
GA + AA genotype of IL-17 (rs2275913) variant after adjusting for diagnosis of AD, delivery 
mode, and feeding type (Fig. 1B). Streptococcus was enriched in infants with AD who had the 
GA + AA genotype versus normal healthy infants who had the GG genotype of IL-17 (Fig. 1C). 
However, Clostridium, Clostridium g4, Clostridium g6, and Lactobacillus did not differ according 
to the genotype of IL-17 variant (rs2275913; Supplementary Fig. S3). Analysis of persistence 
of AD according to Streptococcus mean value and the IL-17 variant rs2275913 showed that AD 
patients with high (above mean) Streptococcus at 6 months of age and the GA + AA genotype of 
IL-17 had more sustained persistence of AD until 12 months of age (Supplementary Table S1). 
In addition, Streptococcus abundance was not associated with the level of total IgE, regardless of 
the IL-17 variant in normal healthy infants (Fig. 2A), but it showed a positive correlation with 
the level of total IgE and SCORAD in infants with AD who had the GA + AA genotype of the 
IL-17 variant, but not in those with the GG genotype (Fig. 2B and C).
Complex association of SCFA-IL-17 variant (rs2275913)-Streptococcus and AD
Butyrate and valerate, but not acetate and propionate, showed a negative correlation with the 
relative abundance of Streptococcus (Fig. 3A-D). The 4 groups according to the IL-17 variant and 
AD showed no significant differences in terms of acetate and propionate levels (Fig. 3E and F). 
However, the abundance of butyrate and valerate was lowest in infants with AD who had the 
GA + AA genotype of IL-17 variant (Fig. 3G and H). In addition, butyrate and valerate were 
negatively correlated with SCORAD at 12 months of age (Supplementary Fig. S4).
Different functional profiles according to IL-17 variant (rs2275913) and AD
The relative abundance of genes associated with oxidative phosphorylation (OXPHOS), 
glycosaminoglycan degradation, PI3K-Akt signaling pathway, focal adhesion, antigen 
processing and presentation, and nucleotide-binding oligomerization domain-containing 
protein (NOD)-like receptor signaling pathway was significantly different among the 4 
groups (Fig. 4A and Supplementary Table S2). Clostridium contributed to differences in the 
expression of genes associated with OXPHOS (Fig. 4B).
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Fig. 1. Altered bacterial microbiota composition in patients with AD. (A) Differences in the gut bacterial communities between the normal healthy and AD groups, 
shown using LDA effect size analysis. (B) The relative abundance of Streptococcus according to the IL-17 variant rs2275913. P value was adjusted by AD, delivery 
mode, and feeding type. (C) The relative abundance of Streptococcus according to the IL-17 variant rs2275913 and AD at 6 months of age. Data are presented as 
mean ± standard error (B, C). 
AD, atopic dermatitis; LDA, linear discriminant analysis.
Gene expression profiling of colonocytes between normal the healthy and AD 
groups
The colonocytes exhibited the most robust changes in gene expression with 651 DEGs 
between normal heathy and AD groups (Supplementary Fig. S5A). The 245 DEGs were up-
regulated and 406 DEGs were down-regulated in infants with AD compared with normal 
subjects. The DEG mainly enriched to GO terms related to cellular process, single-organism 
process, and metabolic process (Supplementary Fig. S5B). Among the genes involved in 
metabolic process and cellular metabolic process (Supplementary Table S3), expression 
of lactate dehydrogenase A-like 6B (LDHAL6B) was higher in AD patients than in normal 
subjects (FC = 1.55 and P = 0.003). This gene is involved in the pathway that synthesizes 
lactate from pyruvate.
Inflammation after stimulation of HIEC-6 cells by IL-17 and S. mitis
To explore whether IL-17 and Streptococcus could affect intestinal inflammation, the expression 
of IL-6 and IL-8 was measured in HIEC-6 cells after stimulation by IL-17 and/or S. mitis. IL-17 
and S. mitis induced the production of IL-6 and IL-8, respectively (Fig. 5). Simultaneous 
stimulation of these 2 factors tended to induce IL-6 and IL-8 to a greater extent than IL-17 or 
S. mitis alone (Fig. 5).
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Fig. 2. Correlation between relative abundance of Streptococcus and total IgE levels according to the genotype of the IL-17 variant rs2275913 in (A) normal 
healthy and (B) AD infants. (C) Correlation between Streptococcus and SCORAD score in AD infants at 6 months of age in AD infants. 
IgE, immunoglobulin E; SCORAD, scoring atopic dermatitis; AD, atopic dermatitis.
DISCUSSION
This study has shown differences in gut microbiota, total IgE, SCORAD, SCFAs, functional 
genes of microbiota, and colonocyte expression according to the IL-17 gene variant rs2275913 
and AD in infants, and increased inflammatory cytokine production following IL-17 and S. 
mitis stimulation in vitro. An abundance of Clostridium or Streptococcus was higher in the healthy 
and AD groups, respectively, and a greater abundance of Streptococcus was seen in infants 
with the GA or AA genotype compared with GG of IL-17 gene variant (rs2275913). Total IgE 
and SCORAD at 6 months of age were positively correlated with Streptococcus abundance in 
infants with AD who had the GA or AA IL-17 variant rs2275913, but not in GG. Butyrate and 
valerate were lowest in infants with AD who had the GA or AA genotype, and were negatively 
correlated with Streptococcus and SCORAD at 12 months of age. In addition, differences in 
functional metabolic genes involved in OXPHOS and the contribution of Clostridium were 
found among groups according to the IL-17 variant and AD. A high LDHAL6B expression was 
demonstrated in colonocytes of AD infants when compared with normal subjects. Moreover, 
411https://e-aair.org https://doi.org/10.4168/aair.2021.13.3.404























































































































































Fig. 3. Correlation between relative abundance of Streptococcus and (A) Acetate, (B) propionate, (C) butyrate, and (D) valerate. Comparison of (E) acetate, (F) 
propionate, (G) butyrate, and (H) valerate according to AD and the IL-17 variant rs2275913. Data are presented as mean ± standard error. 
AD, atopic dermatitis; NS, not significant.
IL-17 and S. mitis induced the production of IL-6 and IL-8 in HIEC-6 cells. Collectively, these 
data demonstrate that the IL-17 variant rs2275913 might be an important host genetic factor 
determining the development of AD in infants via an interaction with the gut microbiota 
and epithelium, and through increased inflammation and reduced SCFAs. These findings 
suggest that the interaction between host genetics and gut microbiota is important in the 
development of AD.
This study is the first to describe an association between the host genetic variant rs2275913 
of IL-17 and the microbiota (Streptococcus) in the development of AD in infants using multi-
omics. Host genetics, immunity, and microbiota are intricately linked. Understanding 
host-microbe interactions is important to gain a better insight into human health. Early in 
the microbiome study, environmental factors, such as diet and medication, were known to 
affect the microbiota24 and host genetics has recently been shown to be an important factor 
determining gut microbiota.10,25 Many studies have used knockout mice to demonstrate 
a relationship between host-specific genes and microbiota. Mice lacking the Card9 gene 
are more susceptible to colitis by alteration of the microbiota,26 and NOD2-deficient mice 
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Fig. 4. (A) Comparison of functional genes related to oxidative phosphorylation and (B) their contributing genus according to AD status and the IL-17 variant 
rs2275913 using whole-metagenome analysis of the gut microbiota in infants. 
AD, atopic dermatitis. 
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Fig. 5. Expression of IL-6 and IL-8 in normal human intestinal epithelial cell-6 cell line after stimulation by IL-7 
and infection with S. mitis. Data are presented as mean ± standard error. 
mRNA, messenger RNA; IL, interleukin. 
*P < 0.05 vs. control group; †P < 0.05 vs. S. mitis (+) group; ‡P < 0.05 vs. IL-17 (+) group.
have a reduced ability to prevent colonization of pathogens.27 Recently, an association 
between single gene variants and microbial taxa was demonstrated in a targeted approach of 
candidate variants, where clear molecular mechanisms have been established. For example, 
a variant in the NOD2 gene that has a well-known relationship with IBD is associated with 
Enterobacteriaceae in patients with IBD.28 The LCT gene, responsible for lactose tolerance, and 
the FUT2 gene, responsible for the transfer of the terminal fucose residues to the mucosal 
glycans, have been associated with the abundance of Bifidobacterium. 
25,29 However, there is no study of the interaction between variants and microbiota in allergic 
diseases. Therefore, the current study presents compelling evidence, although future studies 
will be required to confirm the findings.
The rs2275913 variant in the IL-17 gene promoter is significantly associated with allergic 
disease.19,20,30 Two alleles of rs2275913 differentially have luciferase activity and bind the 
transcription factor NFAT, leading to differences in IL-17 secretion.18 The IL-17 level from 
PHA-stimulated peripheral blood mononuclear cells (PBMCs) of healthy individuals with the 
A allele of rs2275913 was significantly higher than the G allele.18 The plasma level of IL-17 was 
higher in healthy subjects with the AA genotype than with the GG genotype.31 In addition, 
IL-17 contributes to the regulation of S. pyogenes (group A Streptococcus) colonization and 
promotes local cellular infiltration in the female genital tract.17 It can be assumed from these 
previous studies that IL-17 increased by the A allele of rs2275913 may cause the development 
of AD with alterations in the gut microbiota in infants. To assess the influence of IL-17 variant 
only on the gut microbiota, we analyzed the composition of gut microbiota after adjusting 
for AD status, feeding type, and delivery mode, which can affect the gut microbiota. We 
found that Streptococcus was higher in infants with the GA or AA genotype than with the GG 
genotype. A previous study has reported that S. mitis, Streptococcus sangui, and Streptococcus 
gordonii induced IL-6 production in healthy smooth muscle cells.32 In the current study, 
investigation of whether S. mitis induces inflammatory cytokines in HIEC showed increased 
mRNA levels of IL-6 and IL-8 in HIEC-6 cells after stimulation by S. mitis. IL-17 is also known 
to increase IL-6 and IL-8 in HIEC in a dose-dependent manner33 and contribute to chronic 
inflammation.34 Therefore, HIEC-6 cells were cultured with or without IL-17 alone or in 
combination with S. mitis. IL-17 had a greater effect than S. mitis and a 2.5-FC induced greater 
mRNA expression of IL-6 and IL-8 when combined with S. mitis. However, further research is 
required to understand how IL-17 and Streptococcus influence each other.
In general, the gut of infants after birth is an aerobic environment and is initially dominated 
by various facultative bacteria, such as representatives of Enterobacteriaceae, Streptococcus, 
and Staphylococcus.35 Once available oxygen is consumed, anaerobes such as Bifidobacterium, 
Bacteroides, and Clostridium gradually proliferate and eventually establish an anaerobic 
environment in the first year of life.36 Microbial colonization of the infant during this critical 
time is important to maintain homeostasis of the immune system. SCFAs, which are the 
major metabolic products of anaerobic bacterial fermentation, have been suggested to be the 
link between microbiota and host immunity, including inflammation.37 One of the anaerobic 
and butyrate-producing colon bacteria, Clostridium (Clostridiaceae family), was enriched and 
butyrate was higher in the normal healthy group compared with AD. In whole-metagenome 
analysis, functional genes involved in OXPHOS were highest in normal subjects who had the 
GG genotype and Clostridium influenced OXPHOS. Colonocytes utilize bacterially produced 
butyrate as their primary energy source.38 Butyrate is known to stimulate mitochondrial 
OXPHOS39 and Treg cells use OXPHOS to synthesize ATP.40 Butyrate also regulates the 
immune response and Treg/Th17 balance through expansion of Treg cell populations in the 
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colon and peripheral blood.41,42 It is assumed that these steps are a mechanism mediated by 
symbiosis and low levels of IL-17 in normal infants (Fig. 6. left panel). However, Streptococcus 
was markedly increased in the AD group in the current study, and butyrate and valerate were 
lowest in infants with AD who had GA or AA genotypes of the IL-17 variant. Butyrate and 
valerate were negatively correlated with Streptococcus and SCORAD score at 12 months of age. 
Although it is not clear whether Streptococcus directly affected the reduction in SCFAs in the 
current study, the data suggest that SCFA production was reduced by relatively decreased 
anaerobic bacteria due to increased Streptococcus. In addition, we found that S. mitis and IL-17 
induced IL-6 and IL-8 inflammatory cytokines in HIEC cells. SCFAs, particularly butyrate, 
have been shown to decrease the production of IL-6 and IL-17 in PBMCs after stimulation 
with lipopolysaccharide.43 IL-6 and IL-17 are closely connected and each forms a positive 
feedback loop.44 IL-17 decreases the expression of the genes for OXPHOS45 and mitochondrial 
dysfunction-like reduction of OXPHOS induces pro-inflammatory cytokines in the 
intestine.46 Moreover, IL-17 modifies lactate dehydrogenase activity and results in increased 
lactate production in the colon.47 In CD4 T cells, lactate also induces a switch towards the 
Th17 subset.48 Taken together, these data suggest that increased expression of IL-17 by A 
allele of the IL-17 variant rs2275913 and dysbiosis (which can be defined as an increase in 
Streptococcus with an alteration in energy metabolism in gut epithelium) induced intestinal and 
systemic inflammation, leading to the development of AD in early life (Fig. 6. right panel).
Our study has several limitations. First, the number of subjects assessed for SCFA, SCORAD 
at 12 months of age and colonocyte expression was relatively small compared with the 
number assessed for gut microbiota. However, the difference in SCFA among the four groups 
according to IL-17 variant and AD, and the correlation between SCFA and SCORAD, at 12 
months of age was quite clear. Further investigation involving a larger number of subjects 
will be required to confirm these findings. Secondly, we analyzed only one variant of IL-17 
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Fig. 6. Schematic of putative interactions between host gene (IL-17) and microbiota-derived SCFA and metabolism 
on AD development. 
OXPHOS, oxidative phosphorylation; SCFA, short chain fatty acid; AD, atopic dermatitis; IL, interleukin.
to understand IL-17 gene-microbe interactions. There are many variants in the IL-17 gene 
and these may also affect the gut microbiota. However, rs2275913 of IL-17 is located in the 
promoter and affects IL-17 expression level.18 Therefore, this variant can be considered to be 
representative among IL-17 variants. For a more thorough understanding of the association 
between the IL-17 gene and gut microbiota, IL-17 fine mapping could be conducted. Thirdly, 
we used S. mitis to identify the induction of inflammation in vitro despite the absence of 
species level outcomes. There are many species in Streptococcus at genus level, among which 
S. thermophilus is a probiotic that is generally used in the production of yogurt.49 However, 
it is unlikely that the increased Streptococcus seen in the AD group is S. thermophilus because 
almost all probiotics sold in Korea contain Lactobacillus and Bifidobacterium. We selected S. 
mitis for the in vitro study because previous study has reported that previous study have shown 
that it is present in not only the oral but also the intestines,50 moreover S. mitis induces IL-6 
production.32 However, further studies are required to clarify the precise species and to 
understand the role of the gut microbiota in the development of AD.
In conclusions, this study identified a significant association between Streptococcus and AD, 
and the interactions between Streptococcus and the IL-17 variants of the host. Moreover, we 
described how the interactions between genetic factors (IL-17) and the environment (gut 
microbiota) cooperate to result in AD in infants. Our results suggest the possibility that 
alteration of the gut Streptococcus, which may be mediated in part by IL-17 host genetic variants, 
can contribute to the development of AD in infants via intestinal and systemic inflammation 
and a reduction in SCFA. This scheme may represent a new perspective for the etiology of 
allergic diseases associated with gene-host gut microbiome interactions.
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